BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7229976)

  • 1. Pharmacokinetics of dyphylline elimination by uremic patients.
    Lee CC; Wang LH; Majeske BL; Marbury TC
    J Pharmacol Exp Ther; 1981 May; 217(2):340-4. PubMed ID: 7229976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodialysis clearance and total body elimination of carbamazepine during chronic hemodialysis.
    Lee CS; Wang LH; Marbury TC; Bruni J; Perchalski RJ
    Clin Toxicol; 1980 Oct; 17(3):429-38. PubMed ID: 7449356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodialysis clearance of ethosuximide in patients with chronic renal disease.
    Marbury TC; Lee CS; Perchalski RJ; Wilder BJ
    Am J Hosp Pharm; 1981 Nov; 38(11):1757-60. PubMed ID: 7304633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption and disposition of ibuprofen in hemodialyzed uremic patients.
    Senekjian HO; Lee CS; Kuo TH; Au DS; Krothapalli R
    Eur J Rheumatol Inflamm; 1983; 6(2):155-62. PubMed ID: 6673979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodialysis of mefenamic acid in uremic patients.
    Wang LH; Lee CS; Marbury TC
    Am J Hosp Pharm; 1980 Jul; 37(7):956-8. PubMed ID: 7395889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of primidone elimination by uremic patients.
    Lee CS; Marbury TC; Perchalski RT; Wilder BJ
    J Clin Pharmacol; 1982 Jul; 22(7):301-8. PubMed ID: 7107978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theophylline and dyphylline pharmacokinetics in the horse.
    Ayres JW; Pearson EG; Riebold TW; Chang SF
    Am J Vet Res; 1985 Dec; 46(12):2500-6. PubMed ID: 4083583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetics of theophylline and dyphylline following intravenous injection in rabbits.
    Ng PK; Locock RA
    Res Commun Chem Pathol Pharmacol; 1979 Dec; 26(3):509-24. PubMed ID: 523786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance and recovery calculations in hemodialysis: application to plasma, red blood cells, and dialysate measurements for cyclophosphamide.
    Wang LH; Lee CS; Majeske BL; Marbury TC
    Clin Pharmacol Ther; 1981 Mar; 29(3):365-72. PubMed ID: 7471607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Netilmicin pharmacokinetics in uremic patients undergoing hemodialysis.
    Scatizzi A; Basile C; Strippoli P; Di Maggio A; Orbello G; Lodeserto C; Triarico A; Mingrone G; Longo S; Curino E
    Chemioterapia; 1986 Oct; 5(5):327-9. PubMed ID: 3791480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of ceftriaxone in hemodialysis].
    Laville M; Mercatello A; Freney J; Pozet N; Meugnier H; Labeeuw M; Fleurette J; Zech P
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):719-23. PubMed ID: 3309803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyphylline elimination kinetics in lactating women: blood to milk transfer.
    Jarboe CH; Cook LN; Malesic I; Fleischaker J
    J Clin Pharmacol; 1981 Oct; 21(10):405-10. PubMed ID: 7309903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of probenecid on dyphylline elimination.
    May DC; Jarboe CH
    Clin Pharmacol Ther; 1983 Jun; 33(6):822-5. PubMed ID: 6851414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodialysis of acetaminophen in uremic patients.
    Marbury TC; Wang LH; Lee CS
    Int J Artif Organs; 1980 Sep; 3(5):263-6. PubMed ID: 7461859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic aspects of digoxin in patients with terminal renal failure. II. On hemodialysis.
    van der Vijgh WJ
    Int J Clin Pharmacol Biopharm; 1977 Jun; 15(6):255-9. PubMed ID: 881277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary excretion of dyphylline in humans.
    Simons KJ; Simons FE
    J Pharm Sci; 1979 Oct; 68(10):1327-9. PubMed ID: 512873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of orally administered dyphylline.
    Gisclon LG; Ayres JW; Ewing GH
    Am J Hosp Pharm; 1979 Sep; 36(9):1179-84. PubMed ID: 495617
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
    Foote EF; Dreitlein WB; Steward CA; Kapoian T; Walker JA; Sherman RA
    Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clearance calculations in hemodialysis: application to blood, plasma, and dialysate measurements for ethambutol.
    Lee CS; Marbury TC; Benet LZ
    J Pharmacokinet Biopharm; 1980 Feb; 8(1):69-81. PubMed ID: 7381692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.